Brief: Betterlife Successfully Completes Phase 1 And Initiates Phase 2 Clinical Trials With Interferon Alpha-2B In Covid-19 Patients In Chile
29/11/2021 13:12
Nov 29 (Reuters) - BetterLife Pharma Inc BETR.CD :
* BETTERLIFE SUCCESSFULLY COMPLETES PHASE 1 AND INITIATES
PHASE 2
CLINICAL TRIALS WITH INTERFERON ALPHA-2B IN COVID-19 PATIENTS IN
CHILE
* BETTERLIFE PHARMA INC - AP-003 DEMONSTRATED AN EXCELLENT
SAFETY
AND TOLERABILITY PROFILE AND NO SERIOUS ADVERSE EVENTS WERE
OBSERVED
Source text for Eikon: ID:nGNX8lFPzX
Further company coverage: BETR.CD
((Reuters.Briefs@thomsonreuters.com;))
Recent news on BetterLife Pharma
See all newsBrief: Betterlife Pharma Provides Scientific Update On Neuroplastogenic Activity Of BETR-001
Brief: Betterlife Pharma Advanced In IND-enabling Studies For BETR-001
Brief: BetterLife Announces Closing Of $1.168 Million Convertible Debentures To Further Advance IND-Enabling Studies Of Its Non-Hallucinogenic LSD-Based Drug Candidate BETR-001
Brief: Omineca Announces $2 Mln Brokered Financing Of Flow-Through Units
Brief: Betterlife Announces Pricing Of Proposed Offering Of Units